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Clostridium difficile infection in Europe 
B.I. Duerden, J.S. Brazier. PHLS Anaerobe Reference Unit, Universit]) 
qf Wales College ($Medicine, Card8 UK 
The recorded incidence of Clustridium dficile-associated diarrhea 
(CDAD) continues to increase in most European countries, but sur- 
veillance data are inconsistent and incomplete. O f  nine countries 
represented in the European C. dficile Study Group, only five have 
data on the extent of CDAD and four have national case totals- 
Scotland c. 1000, Finland c. 4000, Sweden c. 8000, and England and 
Wales c. 15 500: The numbers reported in England and Wales have 
increased exponentially during the 1990s. Typing for epidemiologic 
purposes is performed in Scotland, Germany, France, Sweden and 
England and Wales by methods that include serotyping, protein 
banding (PAGE), PFGE, AP-PCR, RFLP and PCR-ribotyping. As 
many diagnoses are made by toxin detection, the availability of 
isolates for typing is limited. Both single-strain outbreaks with cross- 
infection and multi-strain clusters related to broad-spectrum anti- 
biotic usage occur. The PHLS Unit has established a library of 100 
P C R  ribotypes; type 1 is widespread among UK hospitals and may 
represent a clone with enhanced survival or virulence characters. The 
ecology of C. dijjcile requires study Healthy carriage appears to be 
low in European adults but C. d@cile has been isolated from animals, 
soil and water. 
Use of indicators for good infection control 
practice 
Is1711 Which indicators can be useful for the 
judgment of antibiotic strategies for antibiotic 
prophylaxis? 
O.B. Jepsen, L.G. Burman, H. Carsauw, P. Gastmeier, V 
Jurkuvenas, A. Sainz, D.L. Monnet, The European Stratexyfor 
Anfibiotic Prophylaxis (ESAP) Project Team, Copenhagen, Drnmark 
Present knowledge of the pros and contras of antibiotic prophylaxis 
calls for a restrictive policy, applying validated antibiotic prophylaxis 
to patients only where adequate documentation for the expected 
effect exists. The current literature, however, shows varying strategies 
for the use of prophylactic antibiotics to prevent postoperative wound 
infections in surgical patients and pneumonia in intensive care 
patients, though sufficient scientific verification already exists for a 
range of well-defined clinical situations allowing discrimination 
between appropriate and inappropriate practice. Within the field of 
infection control, the use of clinical monitoring systems has advanced 
to a point where unvalidated applications should be avoided, and the 
time has come where the focus should be on developing relevant 
indicators for easy monitoring. 
The ESAP (European Strategy for Antibiotic Prophylaxis) project 
applies the essence of this experience to examine antibiotic prophy- 
laxis in a sample of surgical and intensive care patients, and includes 
validation techniques to ensure comparability of data. A guideline 
with examples of good antibiotic prophylaxis (GAP), as well as 
indicators for verification of GAP, are expected to emerge from this 
project. Structural indicators referring to department policy, staff 
training and education, as well as process indicators of timing and 
duration of prophylactic treatment, have been found useful in the 
project’s pilot study and are currently being tested in a larger scale 
study. 
Present status and perspectives of the project will be discussed. 
Is172] Experience with indicators of infection control 
(IC) problems in the course of a multicenter 
quality assurance project (NIDEP 2) 
P. Gastnieier. Institutrfor Hygiene, Free Cniversiry Bcrlin, Berliiz, 
Germany 
Objectives: To evaluate inhcators of IC problems. 
Methods: A prospective controlled intervention study was 
performed in the curgical and intensive care units of eight inediuni- 
sized general hospitals. Data on the structure and process quality were 
recorded at the beginning and the end of the study, as well as 
nosocomial infection (NI) rates, accordmg to the C D C  definitions 
(incidence studies over periods of 8 weeks). Four hocpitals with a 
special interest in IC activities were chosen for intervention, the 
remaining four serving as control hospitals. Four physicians trained 
in IC, one in each hospital, analyzed the situation through observa- 
tion and questionnaires, and aimed at optimizing the IC procedures 
over a period of 2 years, in particular by increasing teaching activities. 
Finally, the incidence density rates for NI at the end ofthe study were 
compared with the rates at the beginning and together analyzed with 
the data for a number of recommended indicators of IC problems. 
Results and conclusion: A total of 76 811 patient days was 
registered at the beginning and the end of the study; the overall 
incidence density of NI was 7.5% in the first period and 6.10/;, at the 
end. A prevented fraction of 25.4% NI (CI 95: 6.140.7) was found 
in the four intervcntion hospitals; the prevented fraction in the four 
control hospitals was 10.0% (CI 95: 15.8-30.1). This reduction ofNI  
was not correlated with a corresponding development of the majority 
of indicators of IC problems. Thus it remains dificult to recommend 
simple and reliable indicators of IC problems. 
Results of repeated prevalence surveys: 
indicator of good practice? 
A. Trilla. Hospital Clinic, Hopital Epidemiulqy, Barreloria, Spain 
Prevalence surveys are of great practical and scientific interest with 
regard to the evolution of a variable whenever the results of multiple, 
periodically repeated studies are available. The EPINE study 
(Prevalence Survey of Nosocomial Infections in Spain) hac been 
conducted every year since 1990 in Spanish hospitals, including a 
‘core’ sample of 64 hospitals. This situation allows the analyeis of 
several features of the EPINE study related to the use of prevalence 
surveys as quality or performance indicators for infection control. 
The EPINE provides hospitals with a measure of riosocomial 
infection rates. Although it is an imperfect and limited measure, 
alternative options for most institutions are either complete ignorance 
of any measure of nosocomial infection rates or the conduction of 
time-consuming and expensive incidence studies. The EPINE study 
is endorsed by the Spanish Health Department, and its annual results 
are widely published and well known. Many Spanish hospitals choose 
to perform the EPINE study as the best simple and economic option 
for limited surveillance of nosocomial infections. Are these data 
useful for improving quality of care? Comparisons are difiicult, and 
there are many confounding factors that make this comparison risky. 
Those hospitals with prevalence rates well above (or below) national 
figures will have to look more closely at what is going on with their 
data. This analysis is best approached by internal. benchmarking 
comparisons of historical data within a single institution. Again, 
methodological shortcomings are lurking everywhere, but repeated 
prevalence studies are a valuable and useful source of information. 
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Identification of nosocomial infection rates 
that are out of control 
W. Scheckler. University of Wisconsin, St. Mary’s Hospital, Madison, 
wr, USA 
Objectives: To review elements necessary for the development of 
reliable nosocomial infection rates and comparison strategies 
appropriate to verify the need to reduce those rates. 
Methods: The National Nosocomial Infection Surveillance 
system (NNIS) of the USAS Center for Disease Control and 
Prevention has become the current de facto US standard for 
definitions used in surveillance of nosocomial infections: both 
numerator-specific infections, and denominators for populations at 
risk for infections. The NNIS system is also a paradigm for hospitals 
to compare specific rates and assess statistically significant differences 
in those rates. Practical issues will be illustrated with cases from the 
author‘s hospital discussing interventions done when rates were out 
of control, issues of thoroughness and comparability of surveillance 
completeness, and pitfalls of inter-hospital comparisons versus intra- 
hospital tracking of rates. Focused surveillance of specific nosocomial 
infections is now recommended, and ‘hospital-wide’ rates are not 
interpretable. Parameter guidelines have been developed for evalu- 
ating outcome indicators with a focus on nosocomial infection 
incidence rates. These guidelines should be used when deciding on 
the selection of rates for monitoring and comparison. 
Results: Twenty-eight years of experience with the NNIS system 
has provided a substantial amount of data for helping to define out- 
of-control nosocomial infection rates. 
Conclusions: Careful application of NNIS methodology, 
selection of incidence rates of nosocomial infection most important 
to the hospital population of interest, and familiarity with issues 
essential in attempts at comparison of one’s own rates with others, 
can lead to better patient care and appropriate public accountability 
Emerging pediatric infectious diseases 
New developments in pediatric pneumococcal 
infections 
R. Dagan. Pediatric Infectious Disease Unit, Soroka University Medical 
Center and the Faculty of Health Sciences, Ben-Gurion University of the 
Negey Beer-Sheva, Israel 
Antibiotic-resistant pneumococci (R-Pnc) are emerging as a cause of 
great burden on pediatric patients and pediatricians. While pneu- 
monia may be most often still treated with the regular regimens, the 
treatment of meningitis calls for a complex and expensive approach 
and the treatment of acute otitis media (AOM) ends often in 
bacteriologic and clinical failures. Although for pediatric meningitis 
several new drugs such as the respiratory quinolones may be helpful, 
it is unlikely that in the next few years the new antibiotics will solve 
most of the problems, especially in AOM. Of the new approaches, 
the two most attractive ones are: (1) withholding antibiotics in cases 
where antibiotic treatment is not absolutely needed, which may 
reduce their use by 50%; and (2) Pnc immunization. Policies and 
guidelines for the reduction idwitholding of antibiotic use in the 
community are urgently needed. Various conjugate Pnc vaccines 
have been shown so far to be safe and immunogenic in infants and 
children. Furthermore, preliminary data show their efficacy in 
reducing Pnc invasive infections and carriage of both Pnc in general 
and R-Pnc in particular. The next 5 years will be of great interest, 
since the success in implementing the new approaches, i.e. the 
reduction of antibiotic use and the role of the new Pnc vaccine, will 
be assessed in detail. 
Viral central nervous system (CNS) infections 
at the end of the 20th century 
L. Szenborn. Clinicfor Pediatric Infectious Diseases, Wroclaw, Poland 
Viral infections of the CNS occur most commonly in childhood. 
Most of them either involve the meninges, as aseptic meningitis 
(AM), or cause a mild clinical syndrome of meningoencephalitis 
rather than the alarming forms of encephalitis. Diagnosis is usually 
based on the combination of clinical assessment, exlusion of other 
causes and specific investigations. They include: EEG, CT, MRI, and 
cerebrospinal fluid (CSF) microscopy and culture. The use of 
polymerase chain reaction (PCR) has improved understanding of the 
etiology and pathogenesis of viral infections of the CNS. Most AM 
cases are associated with non-polio enteroviral (npEV) and mumps 
virus infections. Severe persistent npEV infections have been 
observed in immunocompromised patients, and patients with 
agammaglobulinemia. In mumps, more significant neurologic 
involvement can occur but full recovery is the rule. Herpes simplex 
encephalitis (HE) is the most common sporadic fatal encephalitis in 
the Western world. The clinical presentation of HE ranges from a 
mild illness to diffuse cerebral disease and focal necrotizing lesions. 
Rubella and CMV can cause catastrophic brain infections in the fetus 
and HSV2 in the neonate. VZV can cause a cerebellitis or involve 
cortical gray matter. The outcome of HE is directly related to the 
rapidity of the diagnosis, and immediate implementation of a specific 
antiviral therapy Other viral pathogens in Europe (measles, HHV6, 
HHV7, HIV, EBV and arboviruses) can also cause encephalitis. In 
summary, a high index of suspicion and a rapid diagnostic and 
therapeutic approach may influence the outcome of the ‘treatable’ 
causes of encephalitis. Unfortunately, in the majority of cases, no 
specific treatment is available and supportive therapy is the corner- 
stone of treatment. 
lick-associated infections 
D. Nadal. Ittjectious Diseases, University Children’s Hospital of Zurich, 
Zurich, Switzerland 
Ticks can efficiently transmit a variety of viruses, bacteria, and 
protozoa. This presentation will focus on the most commonly 
diagnosed tick-borne infections in Europe, including arboviruses, 
Borrelia burgdoferi, and the most recently recognized agent of human 
granulocytic ehrlichiosis (HGE). Transmission of these pathogens 
occurs in spring and summer, the seasons of activity of the vectors. 
Most arboviral infections go unrecognized, since they manifest as flu- 
like illnesses. About 10% of infections proceed to involve the central 
nervous system and present with signs and symptoms of meningitis 
or meningoencephalitis. Severe forms are rare in children, who also 
exhibit less neurologic sequelae than adults. Serology is accurate and 
the method of choice to establish etiologic diagnosis. The clinical 
manifestations of B. burgdoferi infection may include cutaneous, 
arthritic, myocardial or neurologic disorders. They appear to be 
somewhat dictated by the nature of the involved B. burgdoferi strain. 
Whereas etiologic diagnosis of skin alterations may rely on clinical 
grounds, diagnosis of other manifestations requires backup by sero- 
logy or detection of B. bugdoferi. Both approaches are burdened with 
obstacles. Human granulocytic ehrlichiosis may present as flu-like 
illness, different rashes, leuko- and thrombocytopenia, and elevation 
of serum transaminase levels. Detection of the agent of HGE in blood 
smears ascertains the diagnosis but has a low sensitivity. Serologic 
